Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-200b-3p AAK1 5.56 0 0.03 0.92614 TargetScan -0.12 1.0E-5 NA
2 hsa-miR-200a-3p ABCA1 6.34 0 0.72 0.28064 mirMAP -0.22 0 NA
3 hsa-miR-200b-3p ABCA1 5.56 0 0.72 0.28064 TargetScan -0.27 0 NA
4 hsa-miR-200b-3p ABCA10 5.56 0 -3.89 5.0E-5 mirMAP -0.15 0.04454 NA
5 hsa-miR-200a-3p ABL2 6.34 0 -0.11 0.76409 MirTarget; miRNATAP -0.14 0 NA
6 hsa-miR-200a-5p ABL2 6.52 0 -0.11 0.76409 mirMAP -0.12 1.0E-5 NA
7 hsa-miR-200b-3p ABL2 5.56 0 -0.11 0.76409 MirTarget -0.17 0 NA
8 hsa-miR-200b-5p ABL2 6.82 0 -0.11 0.76409 mirMAP -0.13 0 NA
9 hsa-miR-200b-3p ACTC1 5.56 0 -6.26 0 MirTarget -0.51 0 NA
10 hsa-miR-200b-3p ADAMTS12 5.56 0 -2.63 0.03543 mirMAP -0.49 0 NA
11 hsa-miR-200b-3p ADAMTS3 5.56 0 -3.48 0.00158 TargetScan -0.49 0 NA
12 hsa-miR-200b-3p ADAMTS5 5.56 0 -6.22 0 mirMAP -0.42 0 NA
13 hsa-miR-200a-3p ADARB1 6.34 0 -2.48 1.0E-5 MirTarget -0.23 0 NA
14 hsa-miR-200b-3p ADCY1 5.56 0 -1.34 0.20446 mirMAP -0.21 0.01035 NA
15 hsa-miR-200b-3p ADCY9 5.56 0 -0.65 0.18271 TargetScan -0.13 0.00051 NA
16 hsa-miR-200a-5p ADD2 6.52 0 -0.63 0.65318 mirMAP -0.31 0.00448 NA
17 hsa-miR-200b-5p ADD2 6.82 0 -0.63 0.65318 mirMAP -0.32 0.00391 NA
18 hsa-miR-200b-5p ADH1B 6.82 0 -10.26 0 mirMAP -0.51 7.0E-5 NA
19 hsa-miR-200a-5p AFF3 6.52 0 -4.69 0 MirTarget -0.37 0 NA
20 hsa-miR-200b-3p AFF3 5.56 0 -4.69 0 MirTarget; TargetScan -0.28 0.00023 NA
21 hsa-miR-200b-5p AFF3 6.82 0 -4.69 0 MirTarget -0.41 0 NA
22 hsa-miR-200a-3p AGPAT4 6.34 0 -1.78 0.03177 mirMAP -0.17 0.00309 NA
23 hsa-miR-200b-3p AHNAK 5.56 0 -1.19 0.03091 TargetScan -0.2 0 NA
24 hsa-miR-200a-5p AKAP2 6.52 0 -3.13 0.04037 mirMAP -0.48 5.0E-5 NA
25 hsa-miR-200b-3p AKAP2 5.56 0 -3.13 0.04037 TargetScan -0.54 1.0E-5 NA
26 hsa-miR-200b-5p AKAP2 6.82 0 -3.13 0.04037 mirMAP -0.54 0 NA
27 hsa-miR-200b-3p AMFR 5.56 0 -0.83 0.0033 TargetScan -0.1 0 NA
28 hsa-miR-200b-5p AMOTL1 6.82 0 -0.99 0.1814 mirMAP -0.26 0 NA
29 hsa-miR-200b-3p AMOTL2 5.56 0 -0.94 0.10811 MirTarget; TargetScan -0.27 0 NA
30 hsa-miR-200a-3p AMZ1 6.34 0 -1.49 0.10286 mirMAP -0.28 1.0E-5 NA
31 hsa-miR-200a-3p ANGPTL1 6.34 0 -8.04 0 MirTarget -0.47 0 NA
32 hsa-miR-200a-3p ANK2 6.34 0 -5.41 0 miRNATAP -0.34 1.0E-5 NA
33 hsa-miR-200b-3p ANKH 5.56 0 -0.63 0.36736 TargetScan -0.28 0 NA
34 hsa-miR-200a-3p ANO6 6.34 0 -1.42 0.00017 MirTarget -0.16 0 NA
35 hsa-miR-200b-3p ANO6 5.56 0 -1.42 0.00017 TargetScan -0.19 0 NA
36 hsa-miR-200b-3p AP1S2 5.56 0 -2.97 0 MirTarget; TargetScan -0.21 0 NA
37 hsa-miR-200a-3p APBB2 6.34 0 -1.53 0.00158 MirTarget; miRNATAP -0.13 0.00019 NA
38 hsa-miR-200b-5p APBB2 6.82 0 -1.53 0.00158 mirMAP -0.18 0 NA
39 hsa-miR-200b-3p APLP2 5.56 0 -0.81 0.06191 TargetScan -0.1 0.00221 NA
40 hsa-miR-200a-3p AR 6.34 0 -4.57 0.00169 mirMAP -0.23 0.02448 24391862 We identified miR-200 b as a downstream target of androgen receptor and linked its expression to decreased tumorigenicity and metastatic capacity of the prostate cancer cells
41 hsa-miR-200a-5p AR 6.52 0 -4.57 0.00169 miRNATAP -0.29 0.01234 24391862 We identified miR-200 b as a downstream target of androgen receptor and linked its expression to decreased tumorigenicity and metastatic capacity of the prostate cancer cells
42 hsa-miR-200b-3p ARHGAP20 5.56 0 -3.56 0.00051 MirTarget; TargetScan -0.44 0 NA
43 hsa-miR-200b-3p ARHGAP28 5.56 0 -2.52 0.04263 MirTarget -0.27 0.0053 NA
44 hsa-miR-200b-3p ARHGAP6 5.56 0 -5.45 0 MirTarget; TargetScan -0.29 6.0E-5 NA
45 hsa-miR-200b-3p ARHGEF17 5.56 0 -2.19 1.0E-5 TargetScan -0.14 0.00021 NA
46 hsa-miR-200b-3p ARHGEF6 5.56 0 -2.31 0.00034 mirMAP -0.28 0 NA
47 hsa-miR-200a-3p ARID5B 6.34 0 -2.21 0 miRNATAP -0.14 0 NA
48 hsa-miR-200b-3p ARID5B 5.56 0 -2.21 0 TargetScan -0.17 0 NA
49 hsa-miR-200a-3p ARL10 6.34 0 -0.75 0.35282 mirMAP -0.27 0 NA
50 hsa-miR-200b-3p ARL10 5.56 0 -0.75 0.35282 mirMAP -0.3 0 NA
51 hsa-miR-200b-3p ARL15 5.56 0 -0.85 0.14947 MirTarget -0.12 0.0075 NA
52 hsa-miR-200b-3p ARL2BP 5.56 0 -0.97 0.00154 TargetScan -0.15 0 NA
53 hsa-miR-200b-3p ASAP1 5.56 0 -0.15 0.71428 MirTarget; TargetScan -0.16 0 NA
54 hsa-miR-200b-3p ATMIN 5.56 0 0.14 0.61266 TargetScan -0.1 0 NA
55 hsa-miR-200b-3p ATP11C 5.56 0 -0.87 0.09047 MirTarget; TargetScan -0.11 0.00516 NA
56 hsa-miR-200a-5p ATP8B4 6.52 0 -2.31 0.00034 MirTarget -0.35 0 NA
57 hsa-miR-200b-5p ATP8B4 6.82 0 -2.31 0.00034 MirTarget -0.37 0 NA
58 hsa-miR-200a-3p BACH2 6.34 0 -2.73 0.00174 mirMAP -0.22 0.00035 NA
59 hsa-miR-200b-3p BACH2 5.56 0 -2.73 0.00174 TargetScan; mirMAP -0.2 0.00386 NA
60 hsa-miR-200b-3p BASP1 5.56 0 -1.12 0.32909 TargetScan -0.73 0 NA
61 hsa-miR-200b-5p BCAT1 6.82 0 -1.6 0.13715 mirMAP -0.24 0.0048 NA
62 hsa-miR-200b-3p BCL11B 5.56 0 2.87 0.00737 TargetScan -0.22 0.00893 NA
63 hsa-miR-200a-5p BCL2 6.52 0 -3.06 1.0E-5 mirMAP -0.2 0.00037 NA
64 hsa-miR-200b-3p BCL2 5.56 0 -3.06 1.0E-5 miRNAWalker2 validate; miRTarBase; TargetScan; mirMAP -0.11 0.03933 NA
65 hsa-miR-200b-5p BCL2 6.82 0 -3.06 1.0E-5 mirMAP -0.2 0.00019 NA
66 hsa-miR-200b-3p BICC1 5.56 0 -2.19 0.09747 TargetScan -0.47 0 NA
67 hsa-miR-200a-3p BICD2 6.34 0 0.86 0.21413 MirTarget; miRNATAP -0.24 0 NA
68 hsa-miR-200b-3p BICD2 5.56 0 0.86 0.21413 TargetScan -0.26 0 NA
69 hsa-miR-200b-3p BLCAP 5.56 0 0.83 0.04875 MirTarget -0.11 0.00051 NA
70 hsa-miR-200b-3p BNC2 5.56 0 -6.04 0 MirTarget; TargetScan -0.49 0 NA
71 hsa-miR-200b-3p BNIP2 5.56 0 -0.41 0.18881 mirMAP -0.11 0 NA
72 hsa-miR-200b-3p C11orf87 5.56 0 -3.96 0.00131 TargetScan -0.33 0.00068 NA
73 hsa-miR-200b-3p C17orf51 5.56 0 -1.61 0.06048 mirMAP -0.24 0.00027 NA
74 hsa-miR-200a-3p C1orf21 6.34 0 -1.27 0.0681 miRNATAP -0.19 5.0E-5 NA
75 hsa-miR-200a-3p C20orf194 6.34 0 -1.86 0.0005 mirMAP -0.11 0.00408 NA
76 hsa-miR-200b-3p C4orf32 5.56 0 -1.52 0.00666 TargetScan -0.2 1.0E-5 NA
77 hsa-miR-200b-3p CAB39 5.56 0 -0.04 0.90683 MirTarget; TargetScan -0.1 0.00021 NA
78 hsa-miR-200b-3p CACNA1C 5.56 0 -5.48 0 MirTarget; TargetScan -0.33 0 NA
79 hsa-miR-200b-3p CACNA2D1 5.56 0 -0.9 0.61165 TargetScan -0.31 0.0254 NA
80 hsa-miR-200b-3p CALU 5.56 0 -0.85 0.0346 MirTarget; TargetScan -0.16 0 NA
81 hsa-miR-200a-3p CAMK4 6.34 0 0.83 0.3952 mirMAP -0.27 7.0E-5 NA
82 hsa-miR-200a-5p CAMK4 6.52 0 0.83 0.3952 mirMAP -0.23 0.00255 NA
83 hsa-miR-200b-5p CAMK4 6.82 0 0.83 0.3952 mirMAP -0.21 0.00602 NA
84 hsa-miR-200a-3p CCDC80 6.34 0 -4.58 0 MirTarget -0.39 0 NA
85 hsa-miR-200a-5p CCDC88A 6.52 0 -0.17 0.77016 miRNATAP -0.13 0.00393 NA
86 hsa-miR-200a-3p CCND2 6.34 0 -2.81 0.0014 MirTarget -0.41 0 NA
87 hsa-miR-200b-3p CCNJL 5.56 0 1.44 0.22112 TargetScan -0.35 0.00016 NA
88 hsa-miR-200a-3p CD274 6.34 0 2.22 0.05161 MirTarget -0.35 1.0E-5 NA
89 hsa-miR-200a-3p CD59 6.34 0 -0.95 0.06737 mirMAP -0.18 0 NA
90 hsa-miR-200a-3p CDC42EP3 6.34 0 -2.44 0.00046 MirTarget -0.24 0 NA
91 hsa-miR-200b-3p CDC42EP3 5.56 0 -2.44 0.00046 TargetScan -0.27 0 NA
92 hsa-miR-200b-3p CDH11 5.56 0 -2.72 0.00843 TargetScan -0.37 0 NA
93 hsa-miR-200a-3p CDK17 6.34 0 -1.12 0.0009 MirTarget; miRNATAP -0.16 0 NA
94 hsa-miR-200b-3p CDK17 5.56 0 -1.12 0.0009 MirTarget; TargetScan -0.19 0 NA
95 hsa-miR-200a-3p CDK6 6.34 0 0.5 0.55124 miRNATAP -0.35 0 24009066 microRNA 200a is an independent prognostic factor of hepatocellular carcinoma and induces cell cycle arrest by targeting CDK6
96 hsa-miR-200b-3p CDK6 5.56 0 0.5 0.55124 mirMAP -0.39 0 NA
97 hsa-miR-200b-3p CDYL2 5.56 0 1.43 0.13708 TargetScan -0.3 6.0E-5 NA
98 hsa-miR-200b-3p CEBPD 5.56 0 -0.71 0.26406 TargetScan -0.12 0.01675 NA
99 hsa-miR-200b-3p CECR2 5.56 0 -0.44 0.80722 TargetScan -0.36 0.00963 NA
100 hsa-miR-200a-3p CECR6 6.34 0 -0.09 0.89824 mirMAP -0.11 0.01604 NA
101 hsa-miR-200a-3p CELF2 6.34 0 -2.48 0.00126 mirMAP -0.23 1.0E-5 NA
102 hsa-miR-200b-3p CELF2 5.56 0 -2.48 0.00126 TargetScan; mirMAP -0.26 1.0E-5 NA
103 hsa-miR-200b-3p CFL2 5.56 0 -3.33 0 MirTarget; TargetScan -0.19 1.0E-5 NA
104 hsa-miR-200a-3p CHRDL1 6.34 0 -10 0 MirTarget -0.59 0 NA
105 hsa-miR-200b-3p CHRDL1 5.56 0 -10 0 MirTarget; TargetScan -0.6 1.0E-5 NA
106 hsa-miR-200b-3p CHST11 5.56 0 0.01 0.99092 mirMAP -0.48 0 NA
107 hsa-miR-200b-3p CHST2 5.56 0 -0.56 0.58452 TargetScan -0.42 0 NA
108 hsa-miR-200b-3p CHSY1 5.56 0 -0.94 0.02225 TargetScan -0.17 0 NA
109 hsa-miR-200b-3p CHSY3 5.56 0 -1.2 0.18667 TargetScan -0.3 2.0E-5 NA
110 hsa-miR-200b-3p CITED2 5.56 0 -2.82 0 TargetScan -0.17 9.0E-5 NA
111 hsa-miR-200a-3p CLIC4 6.34 0 -2.07 1.0E-5 MirTarget -0.22 0 NA
112 hsa-miR-200b-3p CLIC4 5.56 0 -2.07 1.0E-5 MirTarget; TargetScan -0.24 0 NA
113 hsa-miR-200b-3p CLIP1 5.56 0 0.26 0.56626 TargetScan -0.17 0 NA
114 hsa-miR-200b-3p CNN3 5.56 0 -1.93 6.0E-5 MirTarget; TargetScan -0.14 0.00036 NA
115 hsa-miR-200b-3p CNTFR 5.56 0 -4.16 0.0243 TargetScan -0.44 0.00218 NA
116 hsa-miR-200a-3p CNTN1 6.34 0 -2.85 0.12833 MirTarget; miRNATAP -0.29 0.02663 NA
117 hsa-miR-200a-3p COL11A1 6.34 0 -0.79 0.68635 miRNATAP -0.47 0.00044 NA
118 hsa-miR-200a-3p COL15A1 6.34 0 -2.42 0.00253 MirTarget -0.26 0 NA
119 hsa-miR-200b-3p COL4A3 5.56 0 -0.96 0.47491 TargetScan -0.22 0.03396 NA
120 hsa-miR-200a-3p COL8A1 6.34 0 -0.11 0.92773 mirMAP -0.31 0.0001 NA
121 hsa-miR-200b-3p CORO1C 5.56 0 -0.83 0.02048 MirTarget; TargetScan -0.14 0 NA
122 hsa-miR-200a-5p CRIM1 6.52 0 -1.63 0.01982 MirTarget -0.26 0 NA
123 hsa-miR-200b-5p CRIM1 6.82 0 -1.63 0.01982 MirTarget -0.23 2.0E-5 NA
124 hsa-miR-200a-3p CRMP1 6.34 0 -2.48 0.02457 MirTarget -0.24 0.0017 NA
125 hsa-miR-200b-3p CRTAP 5.56 0 -1.99 0 TargetScan -0.19 0 NA
126 hsa-miR-200a-3p CSTA 6.34 0 6.57 0.00078 MirTarget -0.49 0.00028 NA
127 hsa-miR-200a-3p CTSC 6.34 0 1.51 0.01316 mirMAP -0.11 0.01027 NA
128 hsa-miR-200a-5p CUX1 6.52 0 -1.3 0.00108 mirMAP -0.12 7.0E-5 NA
129 hsa-miR-200b-5p CUX1 6.82 0 -1.3 0.00108 mirMAP -0.12 0.00018 NA
130 hsa-miR-200a-5p CWH43 6.52 0 4.53 0.07394 MirTarget -0.41 0.04152 NA
131 hsa-miR-200a-3p CXCL12 6.34 0 -5.99 0 miRNATAP -0.45 0 NA
132 hsa-miR-200b-5p CYLD 6.82 0 -0.05 0.90145 mirMAP -0.13 1.0E-5 NA
133 hsa-miR-200b-3p CYP1B1 5.56 0 -3.73 0.00104 TargetScan -0.33 0.00025 NA
134 hsa-miR-200a-3p CYP26B1 6.34 0 1.59 0.0886 MirTarget; miRNATAP -0.3 0 NA
135 hsa-miR-200b-3p CYTH3 5.56 0 -1.45 0.00123 MirTarget; TargetScan -0.15 1.0E-5 NA
136 hsa-miR-200b-3p DACT1 5.56 0 -3.37 0.00113 TargetScan -0.32 0.0001 NA
137 hsa-miR-200b-3p DCUN1D3 5.56 0 -0.85 0.02366 TargetScan -0.11 0.0001 NA
138 hsa-miR-200b-3p DDIT4 5.56 0 0.48 0.49995 TargetScan -0.15 0.00841 NA
139 hsa-miR-200b-3p DENND2C 5.56 0 1.54 0.23536 TargetScan -0.32 0.00136 NA
140 hsa-miR-200b-3p DENND5B 5.56 0 -2.36 0.00535 MirTarget; TargetScan; mirMAP -0.27 5.0E-5 NA
141 hsa-miR-200b-3p DIXDC1 5.56 0 -4.24 0 MirTarget; TargetScan -0.19 0.00033 NA
142 hsa-miR-200a-3p DLC1 6.34 0 -3.66 0 miRNATAP -0.24 0 NA
143 hsa-miR-200a-5p DLC1 6.52 0 -3.66 0 miRNATAP -0.33 0 NA
144 hsa-miR-200b-3p DLC1 5.56 0 -3.66 0 TargetScan -0.28 0 NA
145 hsa-miR-200b-5p DLK2 6.82 0 1.88 0.20071 MirTarget -0.23 0.04137 NA
146 hsa-miR-200b-3p DMD 5.56 0 -4.18 0.00037 TargetScan -0.46 0 NA
147 hsa-miR-200a-3p DMWD 6.34 0 -0.63 0.04531 MirTarget; miRNATAP -0.1 0 NA
148 hsa-miR-200b-3p DNAJB5 5.56 0 -2.37 0.00017 TargetScan -0.35 0 NA
149 hsa-miR-200b-3p DNAJC18 5.56 0 -2.48 0 TargetScan -0.16 4.0E-5 NA
150 hsa-miR-200b-3p DNM3 5.56 0 -2.57 0.00056 mirMAP -0.14 0.01455 NA
NumGOOverlapSizeP ValueAdj. P Value
1 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 105 1275 8.879e-24 4.131e-20
2 CELL DEVELOPMENT 110 1426 1.205e-22 2.804e-19
3 TISSUE DEVELOPMENT 110 1518 1.611e-20 2.498e-17
4 VASCULATURE DEVELOPMENT 56 469 4.836e-20 4.326e-17
5 CARDIOVASCULAR SYSTEM DEVELOPMENT 74 788 5.578e-20 4.326e-17
6 CIRCULATORY SYSTEM DEVELOPMENT 74 788 5.578e-20 4.326e-17
7 NEUROGENESIS 102 1402 4.022e-19 2.674e-16
8 LOCOMOTION 88 1114 9.93e-19 5.776e-16
9 REGULATION OF CELLULAR COMPONENT MOVEMENT 69 771 1.48e-17 7.651e-15
10 CELL MOTILITY 71 835 7.374e-17 2.639e-14
11 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 109 1672 6.127e-17 2.639e-14
12 LOCALIZATION OF CELL 71 835 7.374e-17 2.639e-14
13 BLOOD VESSEL MORPHOGENESIS 45 364 7.048e-17 2.639e-14
14 REGULATION OF CELL DIFFERENTIATION 101 1492 8.918e-17 2.947e-14
15 CELLULAR COMPONENT MORPHOGENESIS 74 900 9.502e-17 2.947e-14
16 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 53 513 2.888e-16 8.4e-14
17 REGULATION OF CELL PROLIFERATION 96 1496 1.713e-14 4.688e-12
18 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 75 1021 2.362e-14 6.106e-12
19 REGULATION OF NEURON DIFFERENTIATION 52 554 2.857e-14 6.997e-12
20 CELL PROJECTION ORGANIZATION 69 902 4.151e-14 9.657e-12
21 ORGAN MORPHOGENESIS 66 841 4.764e-14 1.056e-11
22 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 71 957 7.765e-14 1.642e-11
23 NEURON DIFFERENTIATION 67 874 9.137e-14 1.848e-11
24 SKELETAL SYSTEM DEVELOPMENT 44 455 1.095e-12 2.049e-10
25 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 56 689 1.135e-12 2.049e-10
26 REGULATION OF CELL DEVELOPMENT 63 836 1.145e-12 2.049e-10
27 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 87 1395 1.732e-12 2.984e-10
28 EMBRYO DEVELOPMENT 65 894 2.41e-12 4.005e-10
29 NEGATIVE REGULATION OF CELL COMMUNICATION 78 1192 2.732e-12 4.383e-10
30 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 58 750 3.407e-12 5.285e-10
31 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 83 1360 1.853e-11 2.782e-09
32 ARTERY DEVELOPMENT 17 75 2.316e-11 3.338e-09
33 REGULATION OF CELL PROJECTION ORGANIZATION 47 558 2.438e-11 3.338e-09
34 UROGENITAL SYSTEM DEVELOPMENT 33 299 2.439e-11 3.338e-09
35 EMBRYONIC MORPHOGENESIS 46 539 2.575e-11 3.423e-09
36 MESENCHYME DEVELOPMENT 26 190 2.818e-11 3.642e-09
37 RESPONSE TO WOUNDING 47 563 3.313e-11 4.167e-09
38 EXTRACELLULAR STRUCTURE ORGANIZATION 33 304 3.815e-11 4.671e-09
39 REGULATION OF CELL ADHESION 50 629 4.411e-11 5.263e-09
40 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 58 801 4.766e-11 5.545e-09
41 BIOLOGICAL ADHESION 68 1032 6e-11 6.809e-09
42 ANGIOGENESIS 32 293 6.474e-11 7.172e-09
43 NEGATIVE REGULATION OF LOCOMOTION 30 263 8.83e-11 9.555e-09
44 NEURON DEVELOPMENT 52 687 1.057e-10 1.117e-08
45 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 72 1142 1.143e-10 1.181e-08
46 HEART DEVELOPMENT 41 466 1.283e-10 1.298e-08
47 REGULATION OF EPITHELIAL CELL PROLIFERATION 31 285 1.433e-10 1.39e-08
48 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 65 983 1.434e-10 1.39e-08
49 INTRACELLULAR SIGNAL TRANSDUCTION 89 1572 1.628e-10 1.546e-08
50 CENTRAL NERVOUS SYSTEM DEVELOPMENT 60 872 1.662e-10 1.546e-08
51 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 11 30 2.736e-10 2.496e-08
52 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 42 498 2.82e-10 2.524e-08
53 NEURON PROJECTION DEVELOPMENT 44 545 4.199e-10 3.687e-08
54 REGULATION OF NEURON PROJECTION DEVELOPMENT 37 408 4.543e-10 3.914e-08
55 NEGATIVE REGULATION OF CELL DIFFERENTIATION 47 609 4.646e-10 3.931e-08
56 EPITHELIUM DEVELOPMENT 62 945 5.421e-10 4.505e-08
57 RESPONSE TO GROWTH FACTOR 40 475 7.95e-10 6.49e-08
58 STEM CELL DIFFERENTIATION 24 190 8.702e-10 6.981e-08
59 RESPONSE TO ENDOGENOUS STIMULUS 82 1450 1.017e-09 8.021e-08
60 POSITIVE REGULATION OF CELL DIFFERENTIATION 56 823 1.068e-09 8.283e-08
61 NEURON PROJECTION MORPHOGENESIS 36 402 1.106e-09 8.437e-08
62 REGULATION OF CELL MORPHOGENESIS 43 552 1.993e-09 1.496e-07
63 POSITIVE REGULATION OF GENE EXPRESSION 92 1733 2.097e-09 1.549e-07
64 SENSORY ORGAN DEVELOPMENT 40 493 2.337e-09 1.699e-07
65 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 96 1848 2.678e-09 1.917e-07
66 REGULATION OF DEVELOPMENTAL GROWTH 29 289 3.702e-09 2.571e-07
67 NEPHRON DEVELOPMENT 18 115 3.65e-09 2.571e-07
68 TAXIS 38 464 4.605e-09 3.151e-07
69 REGULATION OF SYSTEM PROCESS 40 507 5.194e-09 3.502e-07
70 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 33 368 5.358e-09 3.561e-07
71 WOUND HEALING 38 470 6.541e-09 4.279e-07
72 REGULATION OF OSSIFICATION 22 178 6.621e-09 4.279e-07
73 MESENCHYMAL CELL DIFFERENTIATION 19 134 7.317e-09 4.664e-07
74 MUSCLE STRUCTURE DEVELOPMENT 36 432 7.526e-09 4.732e-07
75 HEAD DEVELOPMENT 49 709 7.638e-09 4.739e-07
76 NEGATIVE REGULATION OF CELL PROLIFERATION 46 643 7.842e-09 4.801e-07
77 GLOMERULUS DEVELOPMENT 12 49 8.021e-09 4.847e-07
78 POSITIVE REGULATION OF LOCOMOTION 35 420 1.221e-08 7.286e-07
79 ARTERY MORPHOGENESIS 12 51 1.311e-08 7.721e-07
80 CELL JUNCTION ORGANIZATION 22 185 1.358e-08 7.898e-07
81 CELL PART MORPHOGENESIS 45 633 1.389e-08 7.978e-07
82 TISSUE MORPHOGENESIS 40 533 2.098e-08 1.191e-06
83 ACTIN FILAMENT BASED PROCESS 36 450 2.168e-08 1.206e-06
84 REGULATION OF CELL DEATH 79 1472 2.177e-08 1.206e-06
85 CELL JUNCTION ASSEMBLY 18 129 2.35e-08 1.286e-06
86 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 91 1805 3.148e-08 1.703e-06
87 CONNECTIVE TISSUE DEVELOPMENT 22 194 3.247e-08 1.736e-06
88 POSITIVE REGULATION OF CELL PROLIFERATION 52 814 3.544e-08 1.874e-06
89 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 24 229 3.605e-08 1.885e-06
90 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 60 1008 3.822e-08 1.976e-06
91 REGULATION OF GROWTH 44 633 3.898e-08 1.993e-06
92 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 7 14 3.95e-08 1.998e-06
93 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 28 303 4.135e-08 2.069e-06
94 POSITIVE REGULATION OF MOLECULAR FUNCTION 90 1791 4.423e-08 2.19e-06
95 AMINOGLYCAN METABOLIC PROCESS 20 166 4.966e-08 2.432e-06
96 AMINOGLYCAN BIOSYNTHETIC PROCESS 16 107 5.242e-08 2.541e-06
97 TUBE DEVELOPMENT 40 552 5.45e-08 2.614e-06
98 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 7 15 7.226e-08 3.431e-06
99 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 89 1784 7.415e-08 3.485e-06
100 PROTEOGLYCAN METABOLIC PROCESS 14 83 7.579e-08 3.527e-06
101 NEURON MIGRATION 16 110 7.807e-08 3.597e-06
102 RESPONSE TO HORMONE 54 893 1.161e-07 5.296e-06
103 CELL SUBSTRATE JUNCTION ASSEMBLY 10 41 1.498e-07 6.769e-06
104 RESPONSE TO ALCOHOL 30 362 1.54e-07 6.89e-06
105 REGULATION OF CARTILAGE DEVELOPMENT 12 63 1.619e-07 7.175e-06
106 POSITIVE REGULATION OF NEURON DIFFERENTIATION 27 306 1.853e-07 8.136e-06
107 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 8 24 1.879e-07 8.171e-06
108 CELL CELL SIGNALING 48 767 2.251e-07 9.698e-06
109 EPITHELIAL CELL DIFFERENTIATION 36 495 2.345e-07 1.001e-05
110 REGULATION OF EPITHELIAL CELL MIGRATION 19 166 2.425e-07 1.026e-05
111 RESPONSE TO ORGANIC CYCLIC COMPOUND 54 917 2.707e-07 1.135e-05
112 PROTEIN PHOSPHORYLATION 55 944 2.933e-07 1.218e-05
113 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 16 122 3.371e-07 1.388e-05
114 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 28 337 3.797e-07 1.523e-05
115 FOREBRAIN DEVELOPMENT 29 357 3.771e-07 1.523e-05
116 NEURON PROJECTION GUIDANCE 21 205 3.774e-07 1.523e-05
117 ENDOTHELIAL CELL MIGRATION 11 57 4.633e-07 1.843e-05
118 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 38 554 4.714e-07 1.845e-05
119 KIDNEY EPITHELIUM DEVELOPMENT 16 125 4.72e-07 1.845e-05
120 REGULATION OF CHONDROCYTE DIFFERENTIATION 10 46 4.8e-07 1.861e-05
121 TISSUE MIGRATION 13 84 6.224e-07 2.393e-05
122 POSITIVE REGULATION OF CELL DEVELOPMENT 34 472 6.344e-07 2.42e-05
123 REGULATION OF KERATINOCYTE PROLIFERATION 8 28 7.188e-07 2.719e-05
124 REGULATION OF CHEMOTAXIS 19 180 8.542e-07 3.205e-05
125 REGULATION OF ORGAN GROWTH 12 73 8.633e-07 3.213e-05
126 RESPONSE TO OXYGEN LEVELS 26 311 8.799e-07 3.249e-05
127 CARTILAGE DEVELOPMENT 17 147 8.967e-07 3.285e-05
128 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 56 1004 9.118e-07 3.314e-05
129 REGULATION OF ACTIN FILAMENT BASED PROCESS 26 312 9.35e-07 3.373e-05
130 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 32 437 9.533e-07 3.412e-05
131 SINGLE ORGANISM CELL ADHESION 33 459 9.691e-07 3.442e-05
132 REGULATION OF PHOSPHORUS METABOLIC PROCESS 79 1618 1.053e-06 3.711e-05
133 REGULATION OF BODY FLUID LEVELS 35 506 1.111e-06 3.886e-05
134 SKELETAL SYSTEM MORPHOGENESIS 20 201 1.131e-06 3.927e-05
135 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 14 103 1.176e-06 4.054e-05
136 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 17 153 1.575e-06 5.388e-05
137 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 61 1152 1.617e-06 5.49e-05
138 AORTA DEVELOPMENT 9 41 1.657e-06 5.551e-05
139 NEGATIVE REGULATION OF CELL DEATH 50 872 1.658e-06 5.551e-05
140 AMEBOIDAL TYPE CELL MIGRATION 17 154 1.725e-06 5.733e-05
141 REGULATION OF ANATOMICAL STRUCTURE SIZE 33 472 1.788e-06 5.902e-05
142 CELL FATE COMMITMENT 21 227 2.007e-06 6.576e-05
143 RESPONSE TO STEROID HORMONE 34 497 2.023e-06 6.582e-05
144 REGULATION OF CELL SUBSTRATE ADHESION 18 173 2.038e-06 6.585e-05
145 MUCOPOLYSACCHARIDE METABOLIC PROCESS 14 108 2.099e-06 6.736e-05
146 NEURON FATE COMMITMENT 11 67 2.501e-06 7.971e-05
147 HEART MORPHOGENESIS 20 212 2.595e-06 8.215e-05
148 EAR DEVELOPMENT 19 195 2.858e-06 8.985e-05
149 CELLULAR RESPONSE TO HORMONE STIMULUS 36 552 3.037e-06 9.483e-05
150 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 7 24 3.115e-06 9.6e-05
151 NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 7 24 3.115e-06 9.6e-05
152 CARDIAC CHAMBER DEVELOPMENT 16 144 3.182e-06 9.74e-05
153 EPITHELIAL TO MESENCHYMAL TRANSITION 10 56 3.255e-06 9.836e-05
154 REGULATION OF OSTEOBLAST DIFFERENTIATION 14 112 3.256e-06 9.836e-05
155 POSITIVE REGULATION OF CELL ADHESION 28 376 3.305e-06 9.92e-05
156 MUSCLE TISSUE DEVELOPMENT 23 275 3.718e-06 0.0001109
157 SPROUTING ANGIOGENESIS 9 45 3.79e-06 0.0001123
158 MUSCLE ORGAN DEVELOPMENT 23 277 4.197e-06 0.0001236
159 CELLULAR RESPONSE TO ALCOHOL 14 115 4.464e-06 0.0001306
160 CARDIAC SEPTUM DEVELOPMENT 12 85 4.544e-06 0.0001321
161 REGULATION OF PROTEIN MODIFICATION PROCESS 80 1710 4.588e-06 0.0001326
162 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 17 4.65e-06 0.0001335
163 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 78 1656 4.794e-06 0.0001369
164 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 55 1036 5.05e-06 0.0001424
165 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 55 1036 5.05e-06 0.0001424
166 REGULATION OF EXTENT OF CELL GROWTH 13 101 5.243e-06 0.0001469
167 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 7 26 5.638e-06 0.0001565
168 TUBE MORPHOGENESIS 25 323 5.65e-06 0.0001565
169 NEGATIVE REGULATION OF CELL DEVELOPMENT 24 303 5.865e-06 0.0001608
170 CIRCULATORY SYSTEM PROCESS 27 366 5.876e-06 0.0001608
171 REGULATION OF CELL SIZE 17 172 7.813e-06 0.0002126
172 CELL PROLIFERATION 40 672 7.886e-06 0.0002133
173 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 9 49 7.948e-06 0.0002138
174 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 14 121 8.134e-06 0.0002175
175 GLAND DEVELOPMENT 28 395 8.391e-06 0.0002231
176 FOREBRAIN CELL MIGRATION 10 62 8.445e-06 0.0002233
177 COLLAGEN FIBRIL ORGANIZATION 8 38 8.821e-06 0.000231
178 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 45 799 8.838e-06 0.000231
179 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 16 156 8.989e-06 0.0002337
180 SKIN DEVELOPMENT 19 211 9.044e-06 0.0002338
181 POSITIVE REGULATION OF CATALYTIC ACTIVITY 72 1518 9.179e-06 0.000236
182 RESPONSE TO OXYGEN CONTAINING COMPOUND 67 1381 9.386e-06 0.00024
183 REGULATION OF HYDROLASE ACTIVITY 65 1327 9.533e-06 0.0002415
184 POSITIVE REGULATION OF CELL DEATH 37 605 9.55e-06 0.0002415
185 CARDIAC MUSCLE TISSUE DEVELOPMENT 15 140 1.005e-05 0.0002528
186 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 20 232 1.014e-05 0.0002537
187 MORPHOGENESIS OF AN EPITHELIUM 28 400 1.06e-05 0.0002637
188 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 8 39 1.083e-05 0.0002679
189 REGULATION OF MUSCLE SYSTEM PROCESS 18 195 1.103e-05 0.0002716
190 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 12 93 1.173e-05 0.0002795
191 REGULATION OF CELLULAR COMPONENT SIZE 25 337 1.177e-05 0.0002795
192 ACTIN FILAMENT BASED MOVEMENT 12 93 1.173e-05 0.0002795
193 REGULATION OF HOMEOSTATIC PROCESS 30 447 1.172e-05 0.0002795
194 NEPHRON EPITHELIUM DEVELOPMENT 12 93 1.173e-05 0.0002795
195 RENAL TUBULE DEVELOPMENT 11 78 1.144e-05 0.0002795
196 BEHAVIOR 33 516 1.176e-05 0.0002795
197 POSITIVE REGULATION OF CELL COMMUNICATION 72 1532 1.252e-05 0.0002958
198 RESPONSE TO LIPID 48 888 1.303e-05 0.0003063
199 RHYTHMIC PROCESS 23 298 1.392e-05 0.0003254
200 POSITIVE REGULATION OF GROWTH 20 238 1.477e-05 0.0003437
201 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 13 111 1.493e-05 0.0003455
202 REGULATION OF ION HOMEOSTASIS 18 201 1.669e-05 0.0003827
203 GROWTH 28 410 1.667e-05 0.0003827
204 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 10 67 1.717e-05 0.0003916
205 REGULATION OF TRANSPORT 81 1804 1.798e-05 0.0004081
206 CARDIOBLAST DIFFERENTIATION 5 13 1.869e-05 0.0004222
207 REGULATION OF CELL GROWTH 27 391 1.935e-05 0.000435
208 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 12 98 2.013e-05 0.0004438
209 REGULATION OF ENDOTHELIAL CELL MIGRATION 13 114 1.994e-05 0.0004438
210 EYE DEVELOPMENT 24 326 1.989e-05 0.0004438
211 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 12 98 2.013e-05 0.0004438
212 REGULATION OF KINASE ACTIVITY 43 776 2.074e-05 0.0004553
213 APPENDAGE DEVELOPMENT 16 169 2.462e-05 0.0005327
214 LIMB DEVELOPMENT 16 169 2.462e-05 0.0005327
215 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 9 56 2.46e-05 0.0005327
216 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 18 207 2.483e-05 0.0005349
217 MUSCLE ORGAN MORPHOGENESIS 10 70 2.546e-05 0.0005459
218 TELENCEPHALON DEVELOPMENT 19 228 2.7e-05 0.0005763
219 REGIONALIZATION 23 311 2.745e-05 0.0005833
220 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 5 14 2.84e-05 0.0006006
221 ENDODERM DEVELOPMENT 10 71 2.89e-05 0.0006057
222 MESODERM DEVELOPMENT 13 118 2.89e-05 0.0006057
223 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 15 154 3.147e-05 0.0006566
224 THYMOCYTE AGGREGATION 8 45 3.269e-05 0.0006752
225 T CELL DIFFERENTIATION IN THYMUS 8 45 3.269e-05 0.0006752
226 PROTEOGLYCAN BIOSYNTHETIC PROCESS 9 58 3.289e-05 0.0006752
227 PROTEIN AUTOPHOSPHORYLATION 17 192 3.294e-05 0.0006752
228 POSITIVE REGULATION OF CHEMOTAXIS 13 120 3.456e-05 0.0007054
229 EPIDERMIS DEVELOPMENT 20 253 3.566e-05 0.0007246
230 REGULATION OF VASCULATURE DEVELOPMENT 19 233 3.641e-05 0.0007366
231 BONE DEVELOPMENT 15 156 3.661e-05 0.0007374
232 EMBRYONIC ORGAN DEVELOPMENT 27 406 3.735e-05 0.0007491
233 SYSTEM PROCESS 79 1785 3.803e-05 0.0007529
234 VASCULOGENESIS 9 59 3.785e-05 0.0007529
235 HEART VALVE DEVELOPMENT 7 34 3.791e-05 0.0007529
236 SINGLE ORGANISM BEHAVIOR 26 384 3.837e-05 0.0007566
237 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 8 46 3.86e-05 0.0007579
238 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 74 4.169e-05 0.000815
239 CARDIAC VENTRICLE DEVELOPMENT 12 106 4.446e-05 0.0008656
240 ENDOTHELIUM DEVELOPMENT 11 90 4.514e-05 0.0008751
241 ACTIVATION OF PROTEIN KINASE ACTIVITY 21 279 4.71e-05 0.0009093
242 POSITIVE REGULATION OF KINASE ACTIVITY 30 482 4.828e-05 0.0009282
243 ENSHEATHMENT OF NEURONS 11 91 5.006e-05 0.0009546
244 AXON ENSHEATHMENT 11 91 5.006e-05 0.0009546
245 DIGESTIVE TRACT MORPHOGENESIS 8 48 5.313e-05 0.001009
246 CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 6 25 5.49e-05 0.001038
247 POSITIVE REGULATION OF AXON EXTENSION 7 36 5.602e-05 0.001051
248 T CELL SELECTION 7 36 5.602e-05 0.001051
249 CARDIAC VENTRICLE MORPHOGENESIS 9 62 5.669e-05 0.001056
250 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 15 162 5.673e-05 0.001056
251 CELL CELL ADHESION 35 608 5.762e-05 0.001068
252 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 20 262 5.832e-05 0.001077
253 NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 16 5.913e-05 0.001083
254 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 5 16 5.913e-05 0.001083
255 POSITIVE REGULATION OF RESPONSE TO STIMULUS 83 1929 6.34e-05 0.001157
256 FORMATION OF PRIMARY GERM LAYER 12 110 6.417e-05 0.001166
257 NEUROEPITHELIAL CELL DIFFERENTIATION 9 63 6.451e-05 0.001168
258 CELL SUBSTRATE ADHESION 15 164 6.531e-05 0.001178
259 PLASMA MEMBRANE ORGANIZATION 17 203 6.652e-05 0.001195
260 CORONARY VASCULATURE DEVELOPMENT 7 37 6.742e-05 0.001202
261 CARDIAC MUSCLE CELL ACTION POTENTIAL 7 37 6.742e-05 0.001202
262 ACTION POTENTIAL 11 94 6.768e-05 0.001202
263 GLYCOPROTEIN METABOLIC PROCESS 24 353 7.087e-05 0.001254
264 REGULATION OF ADHERENS JUNCTION ORGANIZATION 8 50 7.194e-05 0.001268
265 REGULATION OF MUSCLE CONTRACTION 14 147 7.335e-05 0.001288
266 MEMBRANE ORGANIZATION 46 899 7.482e-05 0.001309
267 EPITHELIAL CELL DEVELOPMENT 16 186 7.877e-05 0.001367
268 HEMOSTASIS 22 311 7.902e-05 0.001367
269 DEVELOPMENTAL GROWTH 23 333 7.87e-05 0.001367
270 MORPHOGENESIS OF A BRANCHING STRUCTURE 15 167 8.032e-05 0.001384
271 PHOSPHORYLATION 58 1228 8.171e-05 0.001403
272 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 8 51 8.325e-05 0.001419
273 MECHANORECEPTOR DIFFERENTIATION 8 51 8.325e-05 0.001419
274 REGULATION OF AXONOGENESIS 15 168 8.596e-05 0.00146
275 GLAND MORPHOGENESIS 11 97 9.038e-05 0.001529
276 REGULATION OF PHOSPHOLIPASE C ACTIVITY 7 39 9.593e-05 0.001617
277 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 12 115 9.906e-05 0.001659
278 COGNITION 19 251 9.911e-05 0.001659
279 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 67 1492 0.0001025 0.001709
280 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 16 191 0.0001077 0.001789
281 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 20 274 0.0001081 0.001789
282 HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 6 28 0.0001087 0.001793
283 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 8 53 0.0001103 0.001813
284 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 5 18 0.0001107 0.001813
285 REGULATION OF CELL JUNCTION ASSEMBLY 9 68 0.0001186 0.001929
286 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 9 68 0.0001186 0.001929
287 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 54 1135 0.0001206 0.001956
288 REGULATION OF MEMBRANE POTENTIAL 23 343 0.0001225 0.001979
289 METAL ION TRANSPORT 33 582 0.0001241 0.001999
290 POSITIVE REGULATION OF OSSIFICATION 10 84 0.0001246 0.001999
291 CARDIAC MUSCLE TISSUE MORPHOGENESIS 8 54 0.0001263 0.002013
292 VENTRICULAR SEPTUM DEVELOPMENT 8 54 0.0001263 0.002013
293 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 6 29 0.0001338 0.00211
294 CARDIAC MUSCLE CELL CONTRACTION 6 29 0.0001338 0.00211
295 POSITIVE REGULATION OF AXONOGENESIS 9 69 0.000133 0.00211
296 NEGATIVE REGULATION OF GROWTH 18 236 0.0001364 0.002144
297 CELL MATRIX ADHESION 12 119 0.0001377 0.00215
298 HEART PROCESS 10 85 0.0001377 0.00215
299 CRANIAL SKELETAL SYSTEM DEVELOPMENT 8 55 0.0001442 0.002244
300 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 39 740 0.0001449 0.002248
301 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 13 138 0.0001469 0.002272
302 REGULATION OF MUSCLE TISSUE DEVELOPMENT 11 103 0.0001557 0.002399
303 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 7 42 0.0001564 0.002402
304 REGULATION OF CELL SHAPE 13 139 0.000158 0.002419
305 MUSCLE SYSTEM PROCESS 20 282 0.0001593 0.00243
306 CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 6 30 0.0001633 0.002475
307 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 6 30 0.0001633 0.002475
308 CARDIAC CHAMBER MORPHOGENESIS 11 104 0.0001698 0.002565
309 POSITIVE REGULATION OF HYDROLASE ACTIVITY 45 905 0.0001714 0.002581
310 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 4 11 0.0001763 0.002647
311 NEGATIVE REGULATION OF PHOSPHORYLATION 26 422 0.0001785 0.002671
312 SECOND MESSENGER MEDIATED SIGNALING 14 160 0.0001816 0.002685
313 CEREBRAL CORTEX CELL MIGRATION 7 43 0.0001823 0.002685
314 CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS 7 43 0.0001823 0.002685
315 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 13 141 0.0001823 0.002685
316 TRANSMEMBRANE TRANSPORT 52 1098 0.0001808 0.002685
317 ENDOTHELIAL CELL DIFFERENTIATION 9 72 0.0001853 0.00272
318 CYCLIC NUCLEOTIDE METABOLIC PROCESS 8 57 0.0001863 0.002721
319 REGULATION OF ORGAN MORPHOGENESIS 18 242 0.0001866 0.002721
320 CELL PROJECTION ASSEMBLY 19 264 0.0001912 0.002763
321 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 5 20 0.0001911 0.002763
322 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 5 20 0.0001911 0.002763
323 EPIDERMAL CELL DIFFERENTIATION 13 142 0.0001957 0.002818
324 POST EMBRYONIC DEVELOPMENT 10 89 0.0002023 0.002906
325 CELL CHEMOTAXIS 14 162 0.0002068 0.002955
326 REGULATION OF WNT SIGNALING PATHWAY 21 310 0.0002077 0.002955
327 REGULATION OF TRANSMEMBRANE TRANSPORT 26 426 0.000207 0.002955
328 NEGATIVE REGULATION OF CELL ADHESION 17 223 0.0002087 0.002961
329 MULTICELLULAR ORGANISMAL WATER HOMEOSTASIS 8 58 0.0002108 0.002982
330 RESPONSE TO ABIOTIC STIMULUS 49 1024 0.0002191 0.00309
331 REGULATION OF CELL MATRIX ADHESION 10 90 0.000222 0.003111
332 MESONEPHROS DEVELOPMENT 10 90 0.000222 0.003111
333 ACTIN MEDIATED CELL CONTRACTION 9 74 0.000229 0.0032
334 DIVALENT INORGANIC CATION TRANSPORT 19 268 0.0002317 0.003228
335 ENDOCARDIAL CUSHION DEVELOPMENT 6 32 0.0002375 0.00329
336 PROXIMAL DISTAL PATTERN FORMATION 6 32 0.0002375 0.00329
337 CHONDROCYTE DEVELOPMENT 5 21 0.0002451 0.003374
338 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 7 45 0.0002446 0.003374
339 NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 4 12 0.0002586 0.003539
340 POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS 4 12 0.0002586 0.003539
341 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 51 1087 0.0002606 0.003556
342 CELLULAR RESPONSE TO LIPID 27 457 0.0002648 0.003603
343 NEGATIVE REGULATION OF CELL CYCLE 26 433 0.0002668 0.003619
344 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 8 60 0.0002679 0.003624
345 OSSIFICATION 18 251 0.000292 0.003938
346 POSITIVE REGULATION OF CELL GROWTH 13 148 0.0002944 0.003959
347 ION TRANSPORT 57 1262 0.0002996 0.004017
348 MEMBRANE DEPOLARIZATION 8 61 0.0003008 0.004018
349 REGULATION OF PROTEIN BINDING 14 168 0.0003014 0.004018
350 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 26 437 0.0003073 0.004086
351 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 34 0.0003361 0.004417
352 RESPONSE TO FLUID SHEAR STRESS 6 34 0.0003361 0.004417
353 ADHERENS JUNCTION ASSEMBLY 6 34 0.0003361 0.004417
354 CAMP METABOLIC PROCESS 6 34 0.0003361 0.004417
355 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 8 62 0.000337 0.004417
356 MUSCLE CONTRACTION 17 233 0.0003493 0.004565
357 OVULATION CYCLE 11 113 0.0003526 0.004582
358 REGULATION OF STEM CELL DIFFERENTIATION 11 113 0.0003526 0.004582
359 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 13 0.0003652 0.004734
360 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 7 48 0.0003689 0.004756
361 PATTERN SPECIFICATION PROCESS 25 418 0.000369 0.004756
362 DENDRITE DEVELOPMENT 9 79 0.0003765 0.004827
363 CARDIOCYTE DIFFERENTIATION 10 96 0.0003766 0.004827
364 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 81 1977 0.0003796 0.004852
365 EMBRYONIC ORGAN MORPHOGENESIS 19 279 0.0003841 0.004896
366 INNERVATION 5 23 0.0003868 0.004917
367 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 12 133 0.0003901 0.004946
368 DEVELOPMENTAL MATURATION 15 193 0.0003945 0.004988
369 RESPONSE TO NITROGEN COMPOUND 42 859 0.0003987 0.005027
370 PALLIUM DEVELOPMENT 13 153 0.0004065 0.005113
371 ANTERIOR POSTERIOR PATTERN SPECIFICATION 15 194 0.0004168 0.005227
372 REGULATION OF PHOSPHOLIPASE ACTIVITY 8 64 0.00042 0.005253
373 IMMUNE SYSTEM PROCESS 81 1984 0.000423 0.005277
374 MUSCLE CELL DIFFERENTIATION 17 237 0.0004251 0.005289
375 REGULATION OF TRANSFERASE ACTIVITY 45 946 0.0004489 0.00557
376 SYNAPTIC SIGNALING 25 424 0.0004552 0.005634
377 CYTOSKELETON ORGANIZATION 41 838 0.0004605 0.00567
378 GASTRULATION 13 155 0.0004606 0.00567
379 REGULATION OF ERYTHROCYTE DIFFERENTIATION 6 36 0.0004641 0.005697
380 FOCAL ADHESION ASSEMBLY 5 24 0.0004773 0.005799
381 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 24 0.0004773 0.005799
382 CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY 5 24 0.0004773 0.005799
383 ENDODERM FORMATION 7 50 0.0004767 0.005799
384 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 16 218 0.0004837 0.005861
385 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 11 118 0.0005115 0.006182
386 REGULATION OF TRANSPORTER ACTIVITY 15 198 0.0005167 0.006213
387 REGULATION OF CYTOSKELETON ORGANIZATION 28 502 0.0005155 0.006213
388 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 24 404 0.0005285 0.006338
389 REGULATION OF CELL CELL ADHESION 23 380 0.0005305 0.006346
390 REGULATION OF ORGANELLE ORGANIZATION 53 1178 0.0005357 0.006392
391 EXOCYTOSIS 20 310 0.0005448 0.006483
392 REGULATION OF HEART CONTRACTION 16 221 0.0005616 0.006667
393 KERATINOCYTE DIFFERENTIATION 10 101 0.0005659 0.006701
394 REGULATION OF MAPK CASCADE 34 660 0.0005732 0.006767
395 IMMUNE SYSTEM DEVELOPMENT 31 582 0.0005744 0.006767
396 MEMBRANE ASSEMBLY 5 25 0.0005829 0.006798
397 STARTLE RESPONSE 5 25 0.0005829 0.006798
398 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 25 0.0005829 0.006798
399 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 25 0.0005829 0.006798
400 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 9 84 0.0005949 0.00692
401 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 10 102 0.000612 0.007101
402 CALCIUM ION TRANSPORT 16 223 0.0006194 0.007169
403 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 6 38 0.0006271 0.007205
404 MESENCHYME MORPHOGENESIS 6 38 0.0006271 0.007205
405 POSITIVE REGULATION OF ORGAN GROWTH 6 38 0.0006271 0.007205
406 MEMBRANE DOCKING 8 68 0.0006357 0.00725
407 NERVE DEVELOPMENT 8 68 0.0006357 0.00725
408 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 8 68 0.0006357 0.00725
409 REGULATION OF HEMOPOIESIS 20 314 0.0006398 0.007279
410 REGULATION OF CELL ACTIVATION 27 484 0.0006433 0.007301
411 PALATE DEVELOPMENT 9 85 0.000649 0.007348
412 RESPONSE TO KETONE 14 182 0.0006752 0.007626
413 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 7 53 0.0006841 0.00767
414 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 7 53 0.0006841 0.00767
415 REGULATION OF APOPTOTIC SIGNALING PATHWAY 22 363 0.0006835 0.00767
416 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 13 162 0.0007004 0.007829
417 NEGATIVE REGULATION OF OSSIFICATION 8 69 0.0007017 0.007829
418 GANGLIOSIDE METABOLIC PROCESS 5 26 0.0007051 0.007831
419 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 5 26 0.0007051 0.007831
420 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 32 616 0.0007181 0.007955
421 MULTICELLULAR ORGANISMAL SIGNALING 11 123 0.0007264 0.008009
422 ENDOCRINE SYSTEM DEVELOPMENT 11 123 0.0007264 0.008009
423 POSITIVE REGULATION OF HEMOPOIESIS 13 163 0.0007419 0.008161
424 REGULATION OF BLOOD CIRCULATION 19 295 0.000758 0.008318
425 REGULATION OF ION TRANSPORT 31 592 0.0007599 0.008319
426 ODONTOGENESIS 10 105 0.0007689 0.008398
427 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 29 541 0.0007749 0.008405
428 WATER HOMEOSTASIS 8 70 0.000773 0.008405
429 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 29 541 0.0007749 0.008405
430 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 26 465 0.0007783 0.008422
431 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 12 144 0.0007975 0.008609
432 REGULATION OF GTPASE ACTIVITY 34 673 0.0008043 0.008663
433 ESTABLISHMENT OF CELL POLARITY 9 88 0.0008361 0.008922
434 OVULATION CYCLE PROCESS 9 88 0.0008361 0.008922
435 PEPTIDYL TYROSINE MODIFICATION 14 186 0.000836 0.008922
436 REGULATION OF FILOPODIUM ASSEMBLY 6 40 0.0008314 0.008922
437 POSITIVE REGULATION OF HEART GROWTH 5 27 0.0008455 0.008942
438 POSITIVE REGULATION OF FILOPODIUM ASSEMBLY 5 27 0.0008455 0.008942
439 REGULATION OF CATENIN IMPORT INTO NUCLEUS 5 27 0.0008455 0.008942
440 SUBSTRATE DEPENDENT CELL MIGRATION 5 27 0.0008455 0.008942
441 SKIN EPIDERMIS DEVELOPMENT 8 71 0.0008501 0.008949
442 ADHERENS JUNCTION ORGANIZATION 8 71 0.0008501 0.008949
443 CARDIAC MYOFIBRIL ASSEMBLY 4 16 0.0008691 0.009108
444 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 4 16 0.0008691 0.009108
445 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 13 166 0.0008794 0.009195
446 REGULATION OF SEQUESTERING OF CALCIUM ION 10 107 0.0008909 0.009294
447 POSITIVE REGULATION OF MAPK CASCADE 26 470 0.0009089 0.009461
448 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 6 41 0.000951 0.009856
449 REGULATION OF MEMBRANE DEPOLARIZATION 6 41 0.000951 0.009856
NumGOOverlapSizeP ValueAdj. P Value
1 CYTOSKELETAL PROTEIN BINDING 51 819 1.079e-07 3.362e-05
2 ACTIN BINDING 32 393 8.893e-08 3.362e-05
3 PROTEIN KINASE ACTIVITY 43 640 1.448e-07 3.362e-05
4 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 66 1199 1.444e-07 3.362e-05
5 GROWTH FACTOR BINDING 16 123 3.776e-07 7.015e-05
6 MACROMOLECULAR COMPLEX BINDING 72 1399 4.956e-07 7.674e-05
7 MOLECULAR FUNCTION REGULATOR 70 1353 6.007e-07 7.972e-05
8 ENZYME BINDING 83 1737 1.286e-06 0.0001494
9 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 26 328 2.379e-06 0.0002293
10 SEQUENCE SPECIFIC DNA BINDING 56 1037 2.468e-06 0.0002293
11 REGULATORY REGION NUCLEIC ACID BINDING 47 818 3.261e-06 0.0002754
12 PROTEIN COMPLEX BINDING 51 935 5.389e-06 0.0004172
13 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 20 226 6.863e-06 0.0004905
14 CYTOKINE BINDING 12 92 1.048e-05 0.0005823
15 PROTEIN TYROSINE KINASE ACTIVITY 17 176 1.061e-05 0.0005823
16 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 24 315 1.128e-05 0.0005823
17 EXTRACELLULAR MATRIX BINDING 9 51 1.119e-05 0.0005823
18 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 38 629 9.549e-06 0.0005823
19 KINASE ACTIVITY 46 842 1.521e-05 0.0007437
20 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 11 81 1.653e-05 0.0007677
21 DOUBLE STRANDED DNA BINDING 42 764 3.114e-05 0.001378
22 RECEPTOR BINDING 68 1476 4.17e-05 0.001761
23 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 34 588 6.728e-05 0.002717
24 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 9 64 7.321e-05 0.002834
25 CATION CHANNEL ACTIVITY 21 298 0.0001204 0.004474
26 ENZYME REGULATOR ACTIVITY 47 959 0.0001717 0.006135
27 CALCIUM ION BINDING 37 697 0.0001856 0.006385
28 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 17 228 0.0002712 0.008997
NumGOOverlapSizeP ValueAdj. P Value
1 CELL JUNCTION 91 1151 2.177e-19 1.272e-16
2 CELL PROJECTION 108 1786 1.545e-14 4.512e-12
3 MEMBRANE REGION 73 1134 3.212e-11 6.253e-09
4 ANCHORING JUNCTION 42 489 1.605e-10 2.343e-08
5 CELL SUBSTRATE JUNCTION 37 398 2.258e-10 2.637e-08
6 NEURON PART 75 1265 7.384e-10 7.187e-08
7 CELL LEADING EDGE 33 350 1.52e-09 1.268e-07
8 NEURON PROJECTION 60 942 3.234e-09 2.361e-07
9 ACTIN CYTOSKELETON 37 444 4.635e-09 3.008e-07
10 SYNAPSE 51 754 7.592e-09 4.434e-07
11 PLASMA MEMBRANE REGION 56 929 7.397e-08 3.927e-06
12 PLASMA MEMBRANE PROTEIN COMPLEX 36 510 4.814e-07 2.343e-05
13 SYNAPSE PART 40 610 7.423e-07 3.335e-05
14 SITE OF POLARIZED GROWTH 17 149 1.086e-06 4.528e-05
15 CELL PROJECTION PART 53 946 1.594e-06 6.207e-05
16 LAMELLIPODIUM 18 172 1.874e-06 6.84e-05
17 CYTOSKELETON 90 1967 2.649e-06 9.102e-05
18 POSTSYNAPSE 28 378 3.658e-06 0.0001124
19 SOMATODENDRITIC COMPARTMENT 40 650 3.568e-06 0.0001124
20 INTRINSIC COMPONENT OF PLASMA MEMBRANE 78 1649 4.102e-06 0.0001198
21 MEMBRANE MICRODOMAIN 23 288 7.995e-06 0.0002223
22 EXCITATORY SYNAPSE 18 197 1.269e-05 0.0003369
23 SIDE OF MEMBRANE 29 428 1.369e-05 0.0003477
24 PRESYNAPTIC MEMBRANE 9 55 2.117e-05 0.0004819
25 RECEPTOR COMPLEX 24 327 2.091e-05 0.0004819
26 GOLGI APPARATUS 68 1445 2.146e-05 0.0004819
27 INTRACELLULAR VESICLE 61 1259 2.531e-05 0.0005474
28 PROTEINACEOUS EXTRACELLULAR MATRIX 25 356 2.963e-05 0.0006181
29 I BAND 13 121 3.774e-05 0.0007601
30 SYNAPTIC MEMBRANE 20 261 5.529e-05 0.001076
31 EXTRACELLULAR MATRIX 27 426 8.448e-05 0.001591
32 CYTOPLASMIC SIDE OF MEMBRANE 15 170 9.827e-05 0.001722
33 APICAL PART OF CELL 24 361 0.0001002 0.001722
34 CELL CELL JUNCTION 25 383 9.67e-05 0.001722
35 DENDRITE 27 451 0.0002146 0.00358
36 CELL SURFACE 39 757 0.0002299 0.00373
37 GOLGI APPARATUS PART 44 893 0.0002466 0.003893
38 ACTOMYOSIN 8 62 0.000337 0.005047
39 CONTRACTILE FIBER 16 211 0.0003371 0.005047
40 MEMBRANE PROTEIN COMPLEX 48 1020 0.0003701 0.005403
41 CELL BODY 28 494 0.0004003 0.005701
42 VOLTAGE GATED SODIUM CHANNEL COMPLEX 4 14 5e-04 0.00679
43 RUFFLE 13 156 0.0004898 0.00679
44 BASAL PART OF CELL 7 51 0.0005394 0.007159
45 APICAL PLASMA MEMBRANE 19 292 0.0006704 0.0087

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Focal_adhesion_hsa04510 22 199 5.148e-08 2.677e-06
2 PI3K_Akt_signaling_pathway_hsa04151 27 352 2.844e-06 7.395e-05
3 Gap_junction_hsa04540 12 88 6.569e-06 0.0001139
4 Hippo_signaling_pathway_hsa04390 15 154 3.147e-05 0.0003119
5 Apelin_signaling_pathway_hsa04371 14 137 3.37e-05 0.0003119
6 MAPK_signaling_pathway_hsa04010 22 295 3.599e-05 0.0003119
7 Rap1_signaling_pathway_hsa04015 17 206 7.98e-05 0.0005844
8 Regulation_of_actin_cytoskeleton_hsa04810 17 208 8.99e-05 0.0005844
9 Adherens_junction_hsa04520 9 72 0.0001853 0.001071
10 Calcium_signaling_pathway_hsa04020 15 182 0.0002096 0.00109
11 Cell_adhesion_molecules_.CAMs._hsa04514 13 145 0.0002407 0.001116
12 Phospholipase_D_signaling_pathway_hsa04072 13 146 0.0002576 0.001116
13 Ras_signaling_pathway_hsa04014 17 232 0.0003323 0.001329
14 ECM_receptor_interaction_hsa04512 9 82 0.0004976 0.001848
15 Hippo_signaling_pathway_multiple_species_hsa04392 5 29 0.001187 0.004116
16 cGMP_PKG_signaling_pathway_hsa04022 12 163 0.00231 0.007509
17 TGF_beta_signaling_pathway_hsa04350 8 84 0.002534 0.007752
18 FoxO_signaling_pathway_hsa04068 10 132 0.004246 0.01227
19 Jak_STAT_signaling_pathway_hsa04630 11 162 0.006337 0.01734
20 ErbB_signaling_pathway_hsa04012 7 85 0.01015 0.02639
21 p53_signaling_pathway_hsa04115 6 68 0.01224 0.03032
22 Cellular_senescence_hsa04218 10 160 0.0155 0.03664
23 Oocyte_meiosis_hsa04114 8 124 0.02432 0.05498
24 Hedgehog_signaling_pathway_hsa04340 4 47 0.043 0.0903
25 Cytokine_cytokine_receptor_interaction_hsa04060 13 270 0.04341 0.0903
26 Notch_signaling_pathway_hsa04330 4 48 0.0459 0.09181
27 Sphingolipid_signaling_pathway_hsa04071 7 118 0.04971 0.09574
28 Tight_junction_hsa04530 9 170 0.05209 0.09674
29 mTOR_signaling_pathway_hsa04150 8 151 0.06449 0.1152
30 Phagosome_hsa04145 8 152 0.06648 0.1152
31 cAMP_signaling_pathway_hsa04024 9 198 0.1088 0.1824
32 AMPK_signaling_pathway_hsa04152 6 121 0.1275 0.206
33 NF_kappa_B_signaling_pathway_hsa04064 5 95 0.1307 0.206
34 Phosphatidylinositol_signaling_system_hsa04070 5 99 0.1479 0.2162
35 HIF_1_signaling_pathway_hsa04066 5 100 0.1523 0.2162
36 Endocytosis_hsa04144 10 244 0.1533 0.2162
37 Autophagy_animal_hsa04140 6 128 0.1538 0.2162
38 Wnt_signaling_pathway_hsa04310 6 146 0.2308 0.3159
39 Necroptosis_hsa04217 6 164 0.3173 0.423
40 Apoptosis_hsa04210 5 138 0.3496 0.4545
41 ABC_transporters_hsa02010 2 45 0.3636 0.4612
42 Neuroactive_ligand_receptor_interaction_hsa04080 9 278 0.3846 0.4761
43 Lysosome_hsa04142 4 123 0.4583 0.549
44 Cell_cycle_hsa04110 4 124 0.4645 0.549
45 VEGF_signaling_pathway_hsa04370 2 59 0.4987 0.5763
46 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 4 139 0.554 0.6262
47 TNF_signaling_pathway_hsa04668 2 108 0.8126 0.8623

Quest ID: e09726244a5ec2bdf3e7fc1bef37c4fa